Esophagus Prognostic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ Previse, maker of Esopredict, a clinically available test that analyzes methylation of biomarkers to assess the risk of esophageal cancer.

Stephen meltzerDaniel lunzSmall business innovation researchNational institute of diabetesJohns hopkins university school of medicineNational institutes of healthFlagship productDrive further studiesCommercially available barrettEsophagus prognosticNational instituteKidney diseasesNational institutesJohns hopkins university schoolDetection biomarker lab